skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The study of interaction of modified fatty acid with {sup 99m}Tc in alcoholic media

Abstract

The paper presents the results of laboratory research aimed at the development of methods of synthesis of new radiodiagnostic agents based on modified fatty acid labelled with technetium-99m intended for scintigraphic evaluation of myocardial metabolism. In particular, the interaction of substance with {sup 99m}Tc in alcoholic media and the use of ethanol as solvent in the synthesis of the radiopharmaceutical were studied.

Authors:
; ; ; ; ; ; ; ;  [1]; ;  [1];  [2];  [1];  [2]
  1. Institute of Physics and Technology, Tomsk Polytechnic University, Tomsk, 634050 (Russian Federation)
  2. (Russian Federation)
Publication Date:
OSTI Identifier:
22608292
Resource Type:
Journal Article
Resource Relation:
Journal Name: AIP Conference Proceedings; Journal Volume: 1760; Journal Issue: 1; Conference: PC'16: International conference on physics of cancer: Interdisciplinary problems and clinical applications 2016, Tomsk (Russian Federation), 22-25 Mar 2016; Other Information: (c) 2016 Author(s); Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
38 RADIATION CHEMISTRY, RADIOCHEMISTRY AND NUCLEAR CHEMISTRY; CARBOXYLIC ACIDS; ETHANOL; EVALUATION; INTERACTIONS; METABOLISM; RADIOPHARMACEUTICALS; SOLVENTS; SYNTHESIS; TECHNETIUM; TECHNETIUM 99

Citation Formats

Skuridin, V. S., Stasyuk, E. S., Varlamova, N. V., Nesterov, E. A., Sadkin, V. L., Rogov, A. S., E-mail: rogov@tpu.ru, Ilina, E. A., Larionova, L. A., Villa, N. E., Sinilkin, I. G., Zelchan, R. V., Tomsk Cancer Research Institute, Tomsk, 634050, Sazonova, S. I., and Research Institute of Cardiology, Tomsk, 634012. The study of interaction of modified fatty acid with {sup 99m}Tc in alcoholic media. United States: N. p., 2016. Web. doi:10.1063/1.4960282.
Skuridin, V. S., Stasyuk, E. S., Varlamova, N. V., Nesterov, E. A., Sadkin, V. L., Rogov, A. S., E-mail: rogov@tpu.ru, Ilina, E. A., Larionova, L. A., Villa, N. E., Sinilkin, I. G., Zelchan, R. V., Tomsk Cancer Research Institute, Tomsk, 634050, Sazonova, S. I., & Research Institute of Cardiology, Tomsk, 634012. The study of interaction of modified fatty acid with {sup 99m}Tc in alcoholic media. United States. doi:10.1063/1.4960282.
Skuridin, V. S., Stasyuk, E. S., Varlamova, N. V., Nesterov, E. A., Sadkin, V. L., Rogov, A. S., E-mail: rogov@tpu.ru, Ilina, E. A., Larionova, L. A., Villa, N. E., Sinilkin, I. G., Zelchan, R. V., Tomsk Cancer Research Institute, Tomsk, 634050, Sazonova, S. I., and Research Institute of Cardiology, Tomsk, 634012. 2016. "The study of interaction of modified fatty acid with {sup 99m}Tc in alcoholic media". United States. doi:10.1063/1.4960282.
@article{osti_22608292,
title = {The study of interaction of modified fatty acid with {sup 99m}Tc in alcoholic media},
author = {Skuridin, V. S. and Stasyuk, E. S. and Varlamova, N. V. and Nesterov, E. A. and Sadkin, V. L. and Rogov, A. S., E-mail: rogov@tpu.ru and Ilina, E. A. and Larionova, L. A. and Villa, N. E. and Sinilkin, I. G. and Zelchan, R. V. and Tomsk Cancer Research Institute, Tomsk, 634050 and Sazonova, S. I. and Research Institute of Cardiology, Tomsk, 634012},
abstractNote = {The paper presents the results of laboratory research aimed at the development of methods of synthesis of new radiodiagnostic agents based on modified fatty acid labelled with technetium-99m intended for scintigraphic evaluation of myocardial metabolism. In particular, the interaction of substance with {sup 99m}Tc in alcoholic media and the use of ethanol as solvent in the synthesis of the radiopharmaceutical were studied.},
doi = {10.1063/1.4960282},
journal = {AIP Conference Proceedings},
number = 1,
volume = 1760,
place = {United States},
year = 2016,
month = 8
}
  • The interaction with phospholipid vesicles of the membrane-bound respiratory enzyme D-lactate dehydrogenase of Escherichia coli has been studied. Proteolytic digestion studies show that D-lactate dehydrogenase is protected from trypsin digestion to a larger extent when it interacts with phosphatidylglycerol than with phosphatidylcholine vesicles. Wild-type D-lactate dehydrogenase and mutants in which an additional tryptophan is substituted in selected areas by site-specific oligonucleotide-directed mutagenesis have been labeled with 5-fluorotryptophan. {sup 19}F nuclear magnetic resonance studies of the interaction of these labeled enzymes with small unilamellar phospholipid vesicles show that Trp 243, 340, and 361 are exposed to the lipid phase, while Trpmore » 384, 407, and 567 are accessible to the external aqueous phase. Reconstitution of enzymatic activity in phospholipid vesicles has been studied by adding enzyme and substrate to phospholipid vesicles containing a spin-labeled fatty acid as an electron acceptor. The reduction of the doxyl group of the spin-labeled fatty acid has been monitored indirectly by nuclear magnetic resonance and directly by electron paramagnetic resonance. These results indicate that an artificial electron-transfer system can be created by mixing D-lactate dehydrogenase and D-lactate together with phospholipid vesicles containing spin-labeled fatty acids.« less
  • An analogue of the long-chain fatty acid salt, sodium stearate, was synthesized in which the hydrogen atoms at carbons 2, 3, and 18 were replaced by fluorine. The key step in the synthesis was the addition of 3-iodo-2,2,3,3-tetrafluoropropanoic acid amide to 15,15,15-trifluoro-1-pentadecene. Radioactivity was introduced by catalytic reduction of 2,2,3,3,18,18,18-heptafluoro-4-octadecenoic acid amide with carrier-free tritium gas yielding a product with the specific radioactivity of 2.63 TBq/mmol. The resulting 2,2,3,3,18,18,18-heptafluoro-4-octadecenoic acid has a pKa of about 0.5 and is completely dissociated under normal physiological conditions. The fluorinated fatty acid salt analogue is readily taken up into hepatocytes and proved to bemore » metabolically inert. In an approach to the identification of proteins involved in long-chain fatty acid salt transport across membranes and intracellular compartments, the photolabile derivative 11,11-azo-2,2,3,3,18,18,18-heptafluoro(G-3H)octadecanoic acid sodium salt was synthesized with a specific radioactivity of 2.63 TBq/mmol. Photolysis of the photolabile derivative, using a light source with a maximum emission at 350 nm, occurred with a half-life of 1.5 min. The generated carbene reacted with 14C-labeled methanol and acetonitrile with covalent bond formation of 6-13%. Its efficacy for photoaffinity labeling was demonstrated by incorporation into serum albumin, the extracellular fatty acid salt-binding protein, as well as into the intracellular fatty acid salt-binding protein (FABP) of rat liver with the molecular weight of 14,000.« less
  • Fatty acid binding proteins (FABP) have been characterized as facilitating the intracellular solubilization and transport of long-chain fatty acyl carboxylates via noncovalent interactions. More recent work has shown that the adipocyte FABP is also covalently modified in vivo on Cys117 with 4-hydroxy-2-nonenal (4-HNE), a bioactive aldehyde linked to oxidative stress and inflammation. To evaluate 4-HNE binding and modification, the crystal structures of adipocyte FABP covalently and noncovalently bound to 4-HNE have been solved to 1.9 {angstrom} and 2.3 {angstrom} resolution, respectively. While the 4-HNE in the noncovalently modified protein is coordinated similarly to a carboxylate of a fatty acid, themore » covalent form show a novel coordination through a water molecule at the polar end of the lipid. Other defining features between the two structures with 4-HNE and previously solved structures of the protein include a peptide flip between residues Ala36 and Lys37 and the rotation of the side chain of Phe57 into its closed conformation. Representing the first structure of an endogenous target protein covalently modified by 4-HNE, these results define a new class of in vivo ligands for FABPs and extend their physiological substrates to include bioactive aldehydes.« less